Get the Stockscreener App
0.9901
2.93%
-0.0299
After Hours:
.96
-0.0301
-3.04%
Nucana Plc Adr stock is traded at $0.9901, with a volume of 46,276.
It is down -2.93% in the last 24 hours and down -23.84% over the past month.
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
See More
Previous Close:
$1.02
Open:
$1.02
24h Volume:
46,276
Relative Volume:
0.93
Market Cap:
$4.12M
Revenue:
Net Income/Loss:
$-41.08M
P/E Ratio:
-0.0297
EPS:
-33.3184
Net Cash Flow:
$-9.93M
1W Performance:
-9.99%
1M Performance:
-23.84%
6M Performance:
-53.52%
1Y Performance:
-80.74%
1-Day Range:
$0.97
$1.03
1-Week Range:
$0.97
$1.14
52-Week Range:
$0.9484
$5.65
Nucana Plc Adr Stock (NCNA) Company Profile
Compare NCNA vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
0.9901 | 4.12M | 0 | -41.08M | -9.93M | -33.32 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-30-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-03-22 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-22-20 | Initiated | Truist | Buy |
| Jul-24-20 | Initiated | Oppenheimer | Outperform |
| Aug-19-19 | Initiated | H.C. Wainwright | Buy |
| Oct-19-18 | Initiated | Piper Jaffray | Overweight |
| Oct-23-17 | Initiated | Citigroup | Buy |
| Oct-23-17 | Initiated | Jefferies | Buy |
| Oct-23-17 | Initiated | William Blair | Outperform |
View All
Nucana Plc Adr Stock (NCNA) Latest News
NuCana plc (NCNA) Slips 2.75% to $1.06 as Micro-Cap Biotech Tests Range SupportEarnings Quality Factor - siam.in
NuCana stock holds gains as upside is capped by overhead resistance - Traders Union
NuCana plcADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
NuCana plcADR Peer Comparison – Compare with Others - Value Research
NuCana shares fall over 3% as technical selling pressure drives downside gap - Traders Union
NuCana plcADR Key Financial Ratios – Valuation, Profitability & More - Value Research
NuCana stock falls nearly 13% as technical momentum shows overbought conditions and near-term support loss - Traders Union
NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update - Barchart.com
Why is NuCana stock up 3.9% today? - tradersunion.com
What's behind NuCana's latest stock pullback? - Traders Union
NuCana (NCNA) Stock: Retreats 2.63% to $1.48 in the Latest Reading; Price Setup - dars.gov.et
NuCana (NCNA) Stock: Retreats 2.63% to $1.48 in the Latest Reading; Price Setup - dars.gov.et
NuCana (NCNA) Stock: Retreats 2.63% to $1.48 in the Latest Reading; Price Setup - dars.gov.et
NuCana (NCNA) Latest: Records a 2.97% Decrease to $1.50 at the Close; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance in Latest TradingVWAP Deviation - careplusvn.com
NuCana (NCNA) Latest: Records a 2.97% Decrease to $1.50 at the Close; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance in Latest TradingLong Setup Ideas - siam.in
NuCana (NCNA) Latest: Records a 2.97% Decrease to $1.50 at the Close; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance in Latest TradingBPI Reversal - dars.gov.et
NuCana (NCNA) Latest: Records a 2.97% Decrease to $1.50 at the Close; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance in Latest TradingVanna Flow - dars.gov.et
NuCana (NCNA) Latest: Records a 2.97% Decrease to $1.50 at the Close; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance in Latest TradingVolume Breadth - dars.gov.et
NuCana (NCNA) Results Check: The Available Earnings Metric Delivers a Beat in the Current Update; After Results: Shares Close 0.59% LowerHealthcare Earnings Report - careplusvn.com
NuCana (NCNA) Results Check: The Available Earnings Metric Delivers a Beat in the Current Update; After Results: Shares Close 0.59% LowerSegment Revenue Breakdown - dars.gov.et
NuCana (NCNA) Results and Estimates: The Available Earnings Metric Delivers a Beat in the Current Update; Market Reaction: Shares Move 2.39% Up on the DayEarnings Power Value - careplusvn.com
NuCana (NCNA) Results and Estimates: The Available Earnings Metric Delivers a Beat in the Current Update; Market Reaction: Shares Move 2.39% Up on the DayEarnings Turnaround - dars.gov.et
NuCana (NCNA) Results and Estimates: The Available Earnings Metric Delivers a Beat in the Current Update; Market Reaction: Shares Move 2.39% Up on the DayTangible Book Value - dars.gov.et
NuCana (NCNA) Results and Estimates: The Available Earnings Metric Delivers a Beat in the Current Update; Market Reaction: Shares Move 2.39% Up on the DaySurprise Factor Analysis - www.dars.gov.et
NCNA climbs nearly 5% after reporting Q2 results and progress in anti-cancer drug trials - Traders Union
NuCana Reports Second Quarter 2026 Financial Results and Provides Business Update - Barchart.com
NuCana stock rises nearly 5% as firm intraday buying and mixed technical signals drive demand - Traders Union
NuCana (NCNA) Edges Lower to $1.35, Holding Support in a Narrow Trading RangeElliott Wave Entry - careplusvn.com
NuCana (NCNA) Edges Lower to $1.35, Holding Support in a Narrow Trading RangeDebt Free Companies - dars.gov.et
NuCana (NCNA) Edges Lower to $1.35, Holding Support in a Narrow Trading RangeDividend Arbitrage - www.dars.gov.et
Why is NuCana stock up today? Resistance levels in focus - tradersunion.com
NCNA Q3 2024 Earnings: Narrower-Than-Expected Loss Drives 4.76% Share GainDividend Growth Analysis - dars.gov.et
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
NuCana stock rally: Technical outlook - Traders Union
NuCana shares technical analysis: $1.21 support under pressure - Traders Union
Why is NuCana stock rising today? Strong intraday buying limits further downside - Traders Union
Why is NuCana stock up 4.4% today? - Traders Union
What's behind NuCana's latest stock pullback? - Traders Union
NuCana stock slides 3.29% as sellers keep short-term control - Traders Union
NUCANA PLC-ADR (NCNA) Stock Chart - ChartMill
NuCana plc Sponsored ADR Actuals & Estimates (NASDAQ:NCNA) - TradingView
NuCana stock trades up as sellers keep pressure on short-term movement - Traders Union
NuCana stock price forecast: $1.61 support as NCNA falls 7.65% - Traders Union
NuCana stock price forecast: $1.76 support comes into focus as NCNA drops 3.66% - Traders Union
NuCana stock price forecast: $1.76 support comes into focus as NCNA drops 3.66% - tradersunion.com
NuCana stock gains 3.49% as short-term rally lifts price to session highs - Traders Union
NuCana Q3 2024 Earnings: Narrower-than-Expected Loss Drives Stock RallyEPS Surprise History - po-news-eg.net
NuCana stock rises with selling momentum still in control - Traders Union
Buying pressure lifts NuCana stock higher in today's trading - Traders Union
Why is NuCana stock down today? - Traders Union
Nucana Plc Adr Stock (NCNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):